Almeida, Helena http://orcid.org/0000-0002-7434-0839
Traverso, Giovanni
Sarmento, Bruno
das Neves, José http://orcid.org/0000-0002-2317-2759
Article History
Accepted: 21 February 2024
First Online: 19 April 2024
Competing interests
: Financial competing interests for G.T. that may be interpreted as related to the current manuscript include current and prior funding (Supplementary Tables InternalRef removed and InternalRef removed) from Novo Nordisk, CSL Vifor, Hoffman La Roche, Oracle, Draper Laboratory, Massachusetts Institute of Technology (MIT) Lincoln Laboratory, National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering, National Cancer Institute, Advanced Research Projects Agency for Health), Bill and Melinda Gates Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, Karl van Tassel (1925) Career Development Professor, MIT and the Defense Advanced Research Projects Agency, as well as employment by the MIT and Brigham and Women’s Hospital (Supplementary Table InternalRef removed). Personal financial interests include equity/stock (Lyndra Therapeutics, Suono Bio, Vivtex, Celero Systems, Syntis Bio), board of directors membership and/or consulting (Lyndra Therapeutics, Novo Nordisk, Suono Bio, Vivtex, Celero Systems, Syntis Bio) and royalties (past and potentially in the future) from licensed and/or optioned intellectual property (Lyndra Therapeutics, Novo Nordisk, Suono Bio, Vivtex, Celero Systems, Syntis Bio, Johns Hopkins, MIT, and Mass General Brigham Innovation). Complete details of all relationships for-profit and not-for-profit for G.T. can be found in the Supplementary Information. The other authors declare no competing interests.